C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor α, on human monocytes
暂无分享,去创建一个
Y. Devaux | F. Zannad | D. Longrois | P. Lacolley | P. Mertes | C. Seguin-Devaux | V. Regnault | Didier Hanriot | V. Latger‐Cannard | A. Ropars | S. Grosjean | G. Poitevin | Ketsia Hess | Gaelle Bello
[1] D. Sander,et al. High-Sensitivity C-Reactive Protein Is Independently Associated With Early Carotid Artery Progression in Women But Not in Men: The INVADE Study , 2007, Stroke.
[2] N. Suttorp,et al. Adrenomedullin and endothelial barrier function , 2007, Thrombosis and Haemostasis.
[3] J. Tegnér,et al. Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia , 2007, Proceedings of the National Academy of Sciences.
[4] Xian Wang,et al. ROS and NF-κB but not LXR mediate IL-1β signaling for the downregulation of ATP-binding cassette transporter A1 , 2007 .
[5] D. Levy,et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.
[6] W. Hsueh,et al. A Nuclear Receptor Corepressor–Dependent Pathway Mediates Suppression of Cytokine-Induced C-Reactive Protein Gene Expression by Liver X Receptor , 2006, Circulation research.
[7] E. Paffen,et al. C-reactive protein in atherosclerosis: A causal factor? , 2006, Cardiovascular research.
[8] C. Mold,et al. C-Reactive Protein Increases Cytokine Responses to Streptococcus pneumoniae through Interactions with Fcγ Receptors1 , 2006, The Journal of Immunology.
[9] J. Filep,et al. Loss of pentameric symmetry of C‐reactive protein induces interleukin‐8 production through peroxynitrite signaling in human neutrophils , 2005, Circulation research.
[10] Arjun Deb,et al. Proapoptotic, Antimigratory, Antiproliferative, and Antiangiogenic Effects of Commercial C-Reactive Protein on Various Human Endothelial Cell Types In Vitro: Implications of Contaminating Presence of Sodium Azide in Commercial Preparation , 2005, Circulation research.
[11] J. Giddings,et al. C-Reactive Protein–Induced In Vitro Endothelial Cell Activation Is an Artefact Caused by Azide and Lipopolysaccharide , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[12] P. Reitsma,et al. Activation of Inflammation and Coagulation After Infusion of C-Reactive Protein in Humans , 2005, Circulation research.
[13] T. Kodama,et al. Expression of the LXR&agr; Protein in Human Atherosclerotic Lesions , 2005 .
[14] J. Filep,et al. Opposing Effects of C-Reactive Protein Isoforms on Shear-Induced Neutrophil-Platelet Adhesion and Neutrophil Aggregation in Whole Blood , 2004, Circulation.
[15] J. McMurray,et al. The clinical relevance of adrenomedullin: a promising profile? , 2004, Pharmacology & therapeutics.
[16] M. Rutter,et al. C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study , 2004, Circulation.
[17] Paul M Ridker,et al. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? , 2004, Circulation.
[18] V. Fuster,et al. Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology. , 2004, Circulation.
[19] Sidney C. Smith,et al. Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. , 2004, Circulation.
[20] B. Joffe,et al. High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis. , 2004, The Journal of rheumatology.
[21] Prapat Suriyaphol,et al. Possible Protective Role for C-Reactive Protein in Atherogenesis: Complement Activation by Modified Lipoproteins Halts Before Detrimental Terminal Sequence , 2004, Circulation.
[22] Yan Huang,et al. C-Reactive Protein Stimulates MMP-1 Expression in U937 Histiocytes Through Fc&ggr;RII and Extracellular Signal-Regulated Kinase Pathway:: An Implication of CRP Involvement in Plaque Destabilization , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[23] Paolo Raggi,et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. , 2003, The New England journal of medicine.
[24] S. Verma,et al. Biomarkers of Vascular Disease Linking Inflammation to Endothelial Activation: Part II , 2003, Circulation.
[25] S. Verma,et al. New Markers of Inflammation and Endothelial Cell Activation: Part I , 2003, Circulation.
[26] D. Herrington,et al. Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome. , 2003, Cardiovascular research.
[27] Simon C Watkins,et al. Transforming Growth Factor Blocks Tec Kinase Phosphorylation , Ca 2 Influx , and NFATc Translocation Causing Inhibition of T Cell Differentiation , 2003 .
[28] Mark B Pepys,et al. C-reactive protein: a critical update. , 2003, The Journal of clinical investigation.
[29] D. Mangelsdorf,et al. Liver X receptor signaling pathways in cardiovascular disease. , 2003, Molecular endocrinology.
[30] Peter Tontonoz,et al. Liver X Receptor-dependent Repression of Matrix Metalloproteinase-9 Expression in Macrophages* , 2003, The Journal of Biological Chemistry.
[31] Gary L Myers,et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.
[32] C. Mold,et al. C-Reactive Protein Mediates Protection from Lipopolysaccharide Through Interactions With FcγR1 , 2002, The Journal of Immunology.
[33] J. Van Damme,et al. Macrophage inflammatory protein-1. , 2002, Cytokine & growth factor reviews.
[34] A. Seeberger,et al. Elevated cardiac troponin T in peritoneal dialysis patients is associated with CRP and predicts all-cause mortality and cardiac death. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[35] J. Witztum,et al. Innate and acquired immunity in atherogenesis , 2002, Nature Medicine.
[36] S. Barnum,et al. Experimental Allergic Encephalomyelitis Is Inhibited in Transgenic Mice Expressing Human C-Reactive Protein1 , 2002, The Journal of Immunology.
[37] P. Matzinger. The Danger Model: A Renewed Sense of Self , 2002, Science.
[38] R. Schmidt,et al. Lack of specific receptors for C‐reactive protein on white blood cells , 2001, European journal of immunology.
[39] J. Volanakis,et al. Human C-reactive protein: expression, structure, and function. , 2001, Molecular immunology.
[40] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[41] E. Brown,et al. Quantitative analysis of mRNA amplification by in vitro transcription. , 2001, Nucleic acids research.
[42] J. Nilsson,et al. Accumulation of LDL in Rat Arteries Is Associated With Activation of Tumor Necrosis Factor-&agr; Expression , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[43] W. Koenig,et al. C-Reactive Protein in the Arterial Intima: Role of C-Reactive Protein Receptor–Dependent Monocyte Recruitment in Atherogenesis , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[44] D. Bharadwaj,et al. C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific. , 2000, The Journal of clinical investigation.
[45] F. Luscinskas,et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions , 1999, Nature.
[46] I. Kushner,et al. Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.
[47] T. Yamane,et al. Laminar shear stress-induced GRO mRNA and protein expression in endothelial cells. , 1998, Circulation.
[48] J. Filep,et al. Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein. , 1997, The Journal of clinical investigation.
[49] D. Xia,et al. Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[50] H. Nagase. Activation mechanisms of matrix metalloproteinases. , 1997, Biological chemistry.
[51] H. Tilg,et al. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells , 1993, The Journal of experimental medicine.
[52] Irving Kushner,et al. C‐reactive protein increases production of IL‐1α, IL‐1β, and TNF‐α, and expression of mRNA by human alveolar macrophages , 1993, Journal of Leukocyte Biology.
[53] G. Lozanski,et al. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. , 1992, Cytokine.
[54] Andrew W. Taylor,et al. Effect of alpha-2-macroglobulin on cytokine-mediated human C-reactive protein production , 1991, Inflammation.
[55] J. Boudreaux,et al. Nuclear localization of liver X receptor alpha and beta is differentially regulated. , 2007, Journal of cellular biochemistry.
[56] Xian Wang,et al. ROS and NF-kappaB but not LXR mediate IL-1beta signaling for the downregulation of ATP-binding cassette transporter A1. , 2007, American journal of physiology. Cell physiology.
[57] J. Boudreaux,et al. Nuclear localization of liver X receptor α and β is differentially regulated , 2007 .
[58] T. Kodama,et al. Expression of the LXRalpha protein in human atherosclerotic lesions. , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[59] Peter Tontonoz,et al. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors , 2003, Nature Medicine.
[60] C. Mold,et al. C-reactive protein mediates protection from lipopolysaccharide through interactions with Fc gamma R. , 2002, Journal of immunology.
[61] I. Splichal,et al. Induction of inflammatory cytokines by Nocardia fractions. , 1993, Folia biologica.